Determining the Prognostic Value of Continuous Intrathecal Infusion

NCT03523000 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Lumbar Post-Laminectomy Syndrome
Chronic Low Back Pain
Vertebral Compression Fracture
Failed Back Surgery Syndrome

Interventions

OTHER: Continuous intrathecal prognostic infusion test
DRUG: Bupivacaine
DRUG: Fentanyl
DRUG: Placebo
DEVICE: Intrathecal Drug Delivery System (IDDS)

Sponsor

University Hospitals Cleveland Medical Center